English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Correspondence: arturo.chiti@hunimed.eu Humanitas University and Humanitas Research Hospital, Milano, Italy The term “hybrid” in biology refers to an offspring resulting from cross-breeding. Sometimes these hybrids are sterile. This is not the case in imaging, where hybrid “creatures” are giving birth to several “fertile” studies, clinical applications and educational programs. A prominent component of these offspring is represented by publications and this is why EANM and Springer-Nature decided to launch a new imaging journal: the EJHI. In imaging, the adjective hybrid is used when two technologies are used at the same time, or within a short time interval, to study the same patient. The rationale of this approach relies in the possibilities of taking advantage of the combined used of the single techniques. In other words, as it was written years ago: 1 + 1 is more than 2. The medical community is also using the term multimodality imaging, when referring to procedures implying the use of different modalities, not necessarily at the same time. Typical examples are: PET and CT, or SPECT and CT, or PET and MR. Hybrid imaging represents the great majority of the daily workflow in a number of imaging departments across the world at it is used in several research applications. Industries put a lot of efforts in developing hardware and software tools able to make hybrid scanners as effective as single modalities scanners in the daily and research use. How these efforts were successful can be tested by everyone working in the field and can be read in thousands of publications already made with hybrid technologies. Besides new generation scanners, hybrid imaging relies on radiopharmaceuticals. Without radiopharmaceuticals, we would not have seen hybrid imaging like it is today; their diagnostic use in combination with CT, MR, US and optical probes can exploit all the potential of clinical and preclinical imaging. The challenge, from a clinical point of view, it is to have these paired modalities used with their full potentials. Still after several years from the introduction of the technology, we often see duplication of procedures just because one of the hybrid components of imaging is under used or under evaluated. Taking full advantage from the hybrid technology needs a significant effort that can be summarized in few steps. First of all, we need to favour an increased availability of radiopharmaceuticals: many molecules cannot be used due to regulatory constraints that make clinical trials expensive and difficult to run in many countries. Then, the introduction in clinical practice is also expensive and slow, thus reducing the possibilities for the patients to benefit from the technology. Also, different rules apply in different countries, causing inequality in patients’ access to modern diagnostic procedures within the EU.

A new member in the EJNMMI family: the European Journal of Hybrid Imaging